Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01801059 · ClinicalTrials.gov registry record · NA
Patient Activation Intervention in Improving Screening Rates for Colorectal Cancer
A NA study of Colon Cancer and Rectal Cancer, sponsored by Ohio State University Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 284
- Enrollment target
- 1
- Study location
NCT01801059: Completed NA study of Colon Cancer and Rectal Cancer, sponsored by Ohio State University Comprehensive Cancer Center.
NCT01801059 is a NA study of Colon Cancer and Rectal Cancer that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 284 participants, below the 4,453-participant average among 97 other Colon Cancer trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01801059, a NA study of Colon Cancer and Rectal Cancer, has completed, sponsored by Ohio State University Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 284 participants
- Enrollment target
- 1
- Study location
Study Summary
This randomized clinical trial focused on activating the patient to ask their health care provider for a colorectal cancer screening test to improve screening rates for colorectal cancer. The patient activation intervention may increase information seeking, number of screening tests ordered and number of completed screening tests for colorectal cancer.
Primary Outcome
A test of two proportions will be used. If the two groups are different at baseline with respect to key covariates, then a logistic regression model will be used to assess the effect of the intervention on CRC screening controlling for possible confounding variables. The variables that differ between the two groups will be tested as confounders using risk-factor modeling. Summary statistics will be used to describe the time point that subjects receive CRC screening, either after the medical visi
Conditions Studied
Interventions
- OTHER questionnaire administration
- OTHER educational intervention
Study Locations (1)
Ohio
- Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 284 participants |
| Start Date | 2007-09 |
| Est. Completion | 2010-12 |
| Phase | NA |
What the finished NCT01801059 record still lists
NCT01801059 is an interventional study that assigns participants to a tested intervention. The registered 284 participants enrollment target is mid-sized for trials with a published cap, below the 4,453-participant average among 97 other Colon Cancer trials with a reported enrollment target (94% lower).
The record links to 2 conditions, with Colon Cancer appearing as the primary indexed condition, and to 2 interventions - of which questionnaire administration is the first listed.
NCT01801059 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT01801059 about?
NCT01801059 is a clinical study titled "Patient Activation Intervention in Improving Screening Rates for Colorectal Cancer". This randomized clinical trial focused on activating the patient to ask their health care provider for a colorectal cancer screening test to improve screening rates for colorectal cancer. The patient activation intervention may increase information seeking, number of screening tests ordered and numb...
What is the current status of trial NCT01801059?
This trial is currently completed. It is a NA study. The enrollment target is 284 participants. The study started on 2007-09. Estimated completion is 2010-12.
What conditions does trial NCT01801059 study?
This clinical trial studies the following conditions: Colon Cancer, Rectal Cancer.
What interventions are being tested in trial NCT01801059?
The interventions under investigation include: questionnaire administration (OTHER), educational intervention (OTHER).
Who is sponsoring clinical trial NCT01801059?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01801059 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colon Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01801059's enrollment target sits among peer trials
284 29th of 97 higher than 69 of 97 other Colon Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Colon Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
RECRUITING · NA
-
Resilience and Equity in Aging, Cancer, and Health (REACH)
RECRUITING · NA
-
Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit)
RECRUITING · NA
-
PrehabPal: A Digital Tool to Help Older Adults Prepare for Cancer Surgery
RECRUITING · NA
-
EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05263206 · 284 participants · Phase 3
Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)
- NCT05769218 · 284 participants · NA
PrEP and MOUD Rapid Access for Persons Who Inject Drugs: The CHORUS+ Study
- NCT06856577 · 284 participants · Phase 3
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-Related Macular Degeneration
- NCT06963034 · 284 participants · Phase 3
NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia